返回首页
联系我们
下载中心
药大首页
设为首页
English
姓名:张雨萌
性别:女
籍贯:辽宁盘锦
政治面貌:中共党员
联系邮箱:zymshane@126.com
研究方向:
1.药品质量控制及分析新技术开发
2.中药物质基础及药物代谢研究
3.基于单细胞多组学的药物治疗机制研究
职称:讲师
学习/工作经历:
2012年毕业于南京师范大学食品质量与安全专业,获学士学位;同年攻读南京师范大学食品工程硕士,2014年获食品工程硕士学位;2014-2019年就职于大连市食品检验所;2019年-2022年攻读沈阳药科大学药物分析学博士,2022年6月获药物分析学博士学位;2022年8月至今就职于沈阳药科大学药物分析教研室。
所获荣誉:辽宁省食品安全检验检测技能竞赛二等奖
大连市食品安全检验检测技能竞赛二等奖
科研成果:
科研项目:
1.单细胞多组学解析肝纤维化氨代谢微环境变化,辽宁省教育厅(自主选题项目),项目编号LJ212410163031,主持。
2.苯磺酸氨氯地平片、一清片检测新方法开发研究(专利开发),校企合作项目,主持。
论文发表:
1.Zhang YM#, Zhao M#, Jiang X, Qiao QY, Liu TT, Zhao CJ*, Wang M*. Comprehensive analysis of fecal microbiome and metabolomics in hepatic fibrosis rats reveal hepatoprotective effects of Yinchen Wuling Powder from the host-microbial metabolic axis. Frontiers in Pharmacology, 2021, 12: 713197. (IF:5.988)
2.Zhang YM, Liu TT, Zhao YH, Zhao CJ*, Zhao M*. Deciphering the enigma between low bioavailability and high anti-hepatic fibrosis efficacy of Yinchen Wuling powder based on drug metabolism and network pharmacology. Journal of Ethnopharmacology, 2024, 321: 117538. (IF:4.8)
3.Zhang YM#, Zhao M#, Liu YY, Liu TT, Zhao CJ*, Wang M*. Investigation of the therapeutic effect of Yinchen Wuling Powder on CCl4-induced hepatic fibrosis in rats by 1H NMR and MS-based metabolomics analysis. Journal of Pharmaceutical and Biomedical Analysis, 2021, 200: 114073. (IF:3.571)
4.Zhang YM#, Zhao M#, Liu TT, Zhu WJ, Zhao CJ*, Wang M*. Rapid characterization of the chemical constituents of Yinchen Wuling Powder by UPLC coupled with Fourier transform ion cyclotron resonance mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 2021, 198: 114022. (IF:3.571)
5.Yuan B#, Zhang YM#, Man XT, Zhao CJ*, Zhao M*. Magnetic ligand fishing protocol combined with HPLC-FT-ICR-MS for screening potential α-Glucosidase inhibitors from UCG and in silico analysis. Arabian Journal of Chemistry, 2024, 17(9): 105899. (IF:5.3)
6.Weng L#, Zhao M#, Zhang YM#, Liu XY, Wang ZY, Xu RX, Zhang JY, Wang YJ, Wang M*, Zhao CJ*. American ginseng vesicles loaded hyaluronic acid hydrogel for ulcerative colitis. International Journal of Biological Macromolecules, 2025, 288: 138565. (IF:7.7)
7.Zhao YH#, Zhao M#, Wang ZY, Zhao CJ*, Zhang YM*, Wang M*. Danggui Shaoyao San: Chemical characterization and inhibition of oxidative stress and inflammation to treat CCl4-induced hepatic fibrosis. Journal of Ethnopharmacology, 2024, 318: 116870. (IF:4.8)
8.Li ZY#, Zhao M#, Wang ZY, Ma LZ, Pan X, Jin T, Fu ZX, Yuan B, Zhao CJ*, Zhang YM*. Combining metabolomics with network pharmacology to reveal the therapeutic mechanism of Dingchuan Decoction in rats with OVA-induced allergic asthma. Journal of Pharmaceutical and Biomedical Analysis, 2024, 247: 116265. (IF:3.1)
9.Fu ZX#, Zhang YM#, Jin T, Wang ZY, Zhao CJ*, Zhao M*. A comprehensive quality evaluation strategy of Shensong Yangxin capsules based on qualitative, fingerprint and quantitative analyses. Biomedical Chromatography, 2024, 38(4): e5832. (IF:1.8)
10.Pan X#, Zhang YM#, Qiao YY, Cao QY, Wei LX, Zhao M*. Investigation of the therapeutic effect of Hedan tablets on high-fat diet-induced obesity in rats by GC–MS technology and 16S ribosomal RNA gene sequencing. Biomedical Chromatography, 2024, 38(5): e5848. (IF:1.8)
11.Wang ZY#, Zhang YM#, Fu ZX, Jin T, Zhao CJ*, Zhao M*. A comprehensive strategy for quality evaluation of Changan powder by fingerprinting combined with rapid qualitative and quantitative multi-ingredients profiling. Phytochemical Analysis, 2024, 35(4): 840-859. (IF:3.0)
专利:
1.万韬,王洪,李冶,姚洪涛,张子枭,陈光,张雨萌。一种盐酸达克罗宁的合成方法。发明专利,专利号:ZL 2024 1 0390457.1。
2.万韬,王洪,李冶,姚洪涛,陈光,张雨萌。一种可比落的合成工艺。发明专利,专利号:ZL 2024 1 0941737.7。
3.万韬,李冶,张雨萌。一种旋转蒸发仪。实用新型专利,专利号:ZL 2024 2 1645003.6。
4.黄彦辉,张雨萌,万韬,李巍,宋宇,王思雨。一种用于药物制造的离心机。实用新型专利,专利号:ZL 2024 2 0053786.2。
5.李巍,张雨萌,万韬,黄彦辉,宋宇,王思雨。一种具备防堵功能的废水接受罐。实用新型专利,专利号:ZL 2024 2 0054764.8。
指导研究生情况:无
其他:2024、2025年度辽宁省企业科技特派员
上一篇:张译文
下一篇:于淼